Core Insights - Campbell's reported a 1% organic net sales growth for fiscal 2025 Q3, with adjusted EBIT increasing by 2% and adjusted EPS at $0.73, reflecting a 3% year-over-year decline, while full-year adjusted EPS is now expected at the low end of prior guidance [1] Meals and Beverages Performance - The meals and beverages segment achieved a 6% organic net sales growth and a 2% increase in consumption, marking six consecutive quarters of positive in-market consumption [2] - Strong household penetration gains in condensed cooking soups were noted, particularly among millennial consumers, with mac and cheese marketing adding approximately 1 million new households, the largest quarterly gain in four years for this subcategory [2][3] Snacks Segment Challenges - The snacks division experienced a 5% decline in organic net sales, with a 3% drop in consumption attributed to category-wide contraction and company-specific execution issues [4][5] - Recovery prospects for the snacks segment are now pushed into fiscal 2026, with management focusing on price-point strategies, multipack offerings, and targeted innovation to preserve share and margin [5] Cost Management and Acquisition Integration - The company achieved approximately $110 million in cost savings towards a $250 million multi-year target, with the SOVOS acquisition integration unlocking additional efficiencies [6][7] - Despite a 110 basis point contraction in adjusted gross profit margin, disciplined cost controls enabled a 2% adjusted EBIT gain, and acquisition synergies positively impacted adjusted EPS [6][8] Future Outlook - Management reaffirmed FY2025 guidance, now expecting adjusted EPS at the low end of the range, with meals and beverages facing shipment-related headwinds and snacks' full-year operating margin projected at 13% [8] - The FY2025 cost savings target has been raised to $130 million, and the company anticipates capital expenditures at approximately 4.5% of net sales, with tariff-related impacts on adjusted EPS estimated at $0.03–$0.05 [8]

Movado Group (MOV) Q1 2026 Earnings Call May 29, 2025 09:00 AM ET Company Participants Allison Malkin - PartnerEfraim Grinberg - Chairman & CEOSallie Demarsilis - EVP, COO, CFO & Principal Accounting OfficerHamed Khorsand - Principal Operator Good day, everybody, and welcome to Movado First Quarter and Fiscal Year twenty twenty six Earnings Call. As a reminder, today's call is being recorded and may not be reproduced in full or in part without permission from the company. At this time, I would like to turn ...

Financial Data and Key Metrics Changes - For the first quarter, sales were $131.8 million, down 1.9% from $134.4 million last year, or down 1% on a constant currency basis [5][15] - Adjusted operating income decreased to $870,000 from $2.1 million last year [5][18] - Adjusted earnings per share were $0.08, down from $0.09 last year [6][18] - Cash at the end of the quarter was $203.1 million, compared to $225.4 million at the same time last year [19] Business Line Data and Key Metrics Changes - U.S. sales decreased by 1.6%, while international sales were down 2.2%, or 0.7% on a constant currency basis [7][16] - Licensed brands saw strong growth with sales improving by high single digits [8] - Movado brand refresh initiatives, including new product introductions, have received a strong consumer response [7] Market Data and Key Metrics Changes - The retail environment remains uncertain, impacting consumer behavior, particularly in the U.S. and Europe [24] - The outlet division saw an improved trend with sales down only 1.7%, continuing into the second quarter [10] Company Strategy and Development Direction - The company is focused on managing controllables and operating with flexibility while delivering innovation and value [12] - Strategic initiatives include product innovation and cost savings measures, such as reducing marketing expenditures [5][17] - The company is rationalizing its expense infrastructure to improve financial performance [26] Management Comments on Operating Environment and Future Outlook - Management noted that the current economic environment and tariff-related uncertainties have impacted consumer discretionary spending [11][20] - The company is not providing a fiscal 2026 outlook due to macroeconomic uncertainties [20] - There is resilience in the category with young consumers embracing trend-forward watches and jewelry [12] Other Important Information - The company recorded approximately $1.6 million of other non-operating income, primarily from interest earned on its global cash position [18] - Unrealized losses due to currency fluctuations were noted, with management indicating that these will only be realized when paid [30][31] Q&A Session Summary Question: Insights on sales momentum and trends - Management indicated that sales vary by market and brand, with pockets of growth and challenges, but they are satisfied with current sales levels [23] Question: Impact of tariffs on consumer behavior - Management acknowledged that discretionary purchases are challenged and emphasized the importance of delivering value to consumers [24][25] Question: Alignment of earnings per share and cash dividend - Management highlighted a strong balance sheet and expected improved operating cash flow in the second half of the year [28] Question: Unrealized loss in foreign exchange - Management explained that the unrealized loss was due to a decline in the U.S. Dollar and will be mitigated in future quarters [30][31]

Lumen Technologies (LUMN) FY 2025 Conference May 28, 2025 01:50 PM ET Speaker0 Started? Good afternoon. Welcome to day one of our fifty third annual TMT TD Cowen conference. My name is Greg Williams. I cover cable, wireless, and telco here at TD Cowen. I'm joined in this session by Chris Stansberry, the CFO of Lumen Technologies. Chris, thanks for joining us. Speaker1 Yeah, great to be here. Speaker0 I want to start off with the AT and T deal that was announced last week. This deal structure is very unique. ...

Hasbro, Inc. (HAS) is likely to benefit from the strong performance of MAGIC: The Gathering, operational adjustments and licensing partnerships. Also, focus on accelerated cost reductions bodes well. However, an uncertain macro environment is a concern.Let us discuss the factors that suggest why investors should retain the stock for the time being.Hasbro’s Major Growth DriversHasbro’s early momentum in 2025 highlights the effectiveness of its Playing to Win strategy, which centers on high-growth categories ...

Financial Data and Key Metrics Changes - Total reported revenue for Q1 2025 was $693 million, down from $711 million in the prior year, primarily due to lower COVID and donor screening revenue [18] - Excluding COVID and donor screening, the company achieved a mid single-digit revenue growth of 6% [18] - Adjusted EBITDA margin improved by 450 basis points year over year to 23%, with adjusted diluted EPS increasing by 68% to $0.74 [24][25] Business Line Data and Key Metrics Changes - Labs business, accounting for 54% of total revenue, grew by 7%, driven by clinical chemistry and immunoassay testing [10] - Immunohematology business grew by 4%, maintaining its global leadership position [10] - Point of Care business represented 25% of Q1 revenue and grew by 8% excluding COVID, with strong flu sales leading to an 18% year-over-year growth [10] - Molecular Diagnostics business grew by 11% excluding COVID, with ongoing clinical trials for the Savanna respiratory panel [11] Market Data and Key Metrics Changes - Revenue from the "Other" region (Japan, Asia Pacific, Latin America) grew by 12%, driven by a 17% increase in Labs revenue [19] - North America revenue declined by 6% due to lower COVID revenue and donor screening wind down, but grew by 5% when excluding these factors [19] - Europe, Middle East, and Africa grew by 9%, while China revenue remained flat, primarily due to order timing and decreased Triage revenue [20] Company Strategy and Development Direction - The company is focused on a narrow set of strategic initiatives, including increasing platform content and utility, expanding margins, and enhancing commercial execution [11] - Plans to realize $100 million in annualized cost savings, with $50 million expected in the first half of 2025 [12] - The company aims to maintain its manufacturing footprint and continue investing in U.S.-based manufacturing and R&D [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's strategy and operational discipline, highlighting strong Q1 results and ongoing initiatives [9] - The company anticipates potential tariff impacts of $30 million to $40 million in 2025 but believes mitigation plans will offset these impacts [15] - Full-year 2025 financial guidance remains unchanged, with expectations for total reported revenue between $2.6 billion and $2.81 billion [27] Other Important Information - The company has invested nearly $1 billion in U.S.-based manufacturing and R&D over the past three years [13] - Adjusted free cash flow for Q1 2025 was $47 million, representing 29% of adjusted EBITDA [26] - The company plans to refinance its debt in the second half of 2025 or early 2026, depending on market conditions [31] Q&A Session Summary Question: Can you elaborate on the tariff impact and pricing actions? - Management indicated that selective pricing actions are being considered to offset tariff impacts, but competitive market conditions must be taken into account [36][37] Question: Will tariff impacts affect long-term manufacturing plans? - Management does not expect changes to the overall manufacturing footprint, emphasizing the importance of their global manufacturing network [38] Question: How confident is the company in mitigating tariff impacts? - Management expressed confidence in fully mitigating tariff impacts through various actions, including cost reductions and realigning inventories [43] Question: What underpins the confidence in China's growth rate? - Confidence in mid to high single-digit growth in China is based on strong performance in labs and immunohematology, despite some softness in Triage sales [49] Question: What is the status of the Savanna program? - The company is focused on completing the RBP4x submission to the FDA and is not speculating on outcomes beyond that [45][61] Question: How is the respiratory sales performance impacting guidance? - Management expects to maintain the guidance range for COVID revenue despite a decline, as flu sales have been strong [56][58]

- Beverage-grade Liquid CO2 Processor Acquisition and Corporate Reorganization Deliver Improved Year- over-Year Gross Margin and Adjusted EBITDA - PEKIN, Ill., May 07, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, reported its financial results for the quarter ended March 31, 2025. Bryon McGregor, President and Chief Executive Officer of Alto Ingredients said, "During the first quarter of 2 ...

Coty (COTY) Q3 2025 Earnings Call May 07, 2025 08:00 AM ET Company Participants Robert Ottenstein - Senior Managing Director & PartnerSue Nabi - CEOFilippo Falorni - Director - Equity ResearchLaurent Mercier - CFOBonnie Herzog - Managing Director Olivia Tong - Managing DirectorAshley Helgans - Senior Vice PresidentAnna Lizzul - Vice President - Equity Research Conference Call Participants Susan Anderson - Managing Director & Senior AnalystKorinne Wolfmeyer - Vice President & Senior Equity Research Analyst - ...

Coty (COTY) Q3 2025 Earnings Call May 07, 2025 08:00 AM ET Speaker0 My name is Chelsea, and I'll be your conference operator today. At this time, I would like to welcome everyone to CODI's Third Quarter Fiscal twenty twenty five Question and Answer Conference Call. As a reminder, this conference call is being recorded today, 05/07/2025 at 08:00 a. M. Eastern Time or 02:00 p. M. Central European Time. Please note that on May 6 at approximately 04:30 p. M. Eastern Time or 10:30 p. M. Central European Time, CO ...

Cabot (CBT) Q2 2025 Earnings Call May 06, 2025 08:00 AM ET Company Participants Steven Delahunt - VP of Investor Relations & TreasurerSean Keohane - Director, President & CEOErica McLaughlin - EVP, CFO and Head of Corporate StrategyJohn Roberts - Managing DirectorJosh Spector - Executive DirectorDan Rizzo - Senior Vice President Conference Call Participants Jeffrey Zekauskas - Analyst Operator Good day and thank you for standing by. Welcome to the Cabot Second Quarter twenty twenty five Earnings Conference ...